Thielemann et al. noted a related association, identifying the IL17A rs2275913 minor allele variant as a risk factor for fibrosis progression in MASLD patients, highlighting its significance in inflammation and immune dysregulation [26]. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatotic liver disease.